No evidence for linkage between the hereditary angioedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F11%3A%230000231" target="_blank" >RIV/00209775:_____/11:#0000231 - isvavai.cz</a>

Výsledek na webu

<a href="http://onlinelibrary.wiley.com/doi/10.1111/4j..136-3083.2011.02547.x/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/4j..136-3083.2011.02547.x/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/j.1365-3083.2011.02547.x" target="_blank" >10.1111/j.1365-3083.2011.02547.x</a>

Jazyk výsledku

angličtina

Název v původním jazyce

No evidence for linkage between the hereditary angioedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene

Popis výsledku v původním jazyce

Hereditary angiooedema (HAE) is a life-threatening disease with poor clinical phenotype correlation with its casual mutation in the C1 inhibitor (SERPING1) gene. It is characterized by substantial symptom variability even in affected members of the samefamily. Therefore, it is likely that genetic factors outside the SERPING1 gene have an influence on disease manifestation. In this study, functional polymorphisms in genes with a possible desease-modifying effect, B1 and B2 bradykinin receptors (BDKR1, BDKR2), angiotensin-converting enzyme (ACE) and mannose-binding lectin (MBL2), were analysed in 36 unrelated HAE patients. The same analysis was carried out in 69 HAE patients regardless of their familial relationship. No significant influence of the studied polymorphisms in the BDKR1, BDKR2, ACE and MBL2 genes on overall disease severity, localization and severity of particular attacks, frequency of oedema episodes or age of disease onset was detected in either group of patients. Other g

Název v anglickém jazyce

No evidence for linkage between the hereditary angioedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene

Popis výsledku anglicky

Hereditary angiooedema (HAE) is a life-threatening disease with poor clinical phenotype correlation with its casual mutation in the C1 inhibitor (SERPING1) gene. It is characterized by substantial symptom variability even in affected members of the samefamily. Therefore, it is likely that genetic factors outside the SERPING1 gene have an influence on disease manifestation. In this study, functional polymorphisms in genes with a possible desease-modifying effect, B1 and B2 bradykinin receptors (BDKR1, BDKR2), angiotensin-converting enzyme (ACE) and mannose-binding lectin (MBL2), were analysed in 36 unrelated HAE patients. The same analysis was carried out in 69 HAE patients regardless of their familial relationship. No significant influence of the studied polymorphisms in the BDKR1, BDKR2, ACE and MBL2 genes on overall disease severity, localization and severity of particular attacks, frequency of oedema episodes or age of disease onset was detected in either group of patients. Other g

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FN - Epidemiologie, infekční nemoci a klinická imunologie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Scandinavian journal of immunology

ISSN

0300-9475

e-ISSN

—

Svazek periodika

74

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

NO - Norské království

Počet stran výsledku

7

Strana od-do

100-106

Kód UT WoS článku

000292254900013

EID výsledku v databázi Scopus

—